Affordable Access

Publisher Website

Effects of oral iron chelator deferasirox on human malignant lymphoma cells

Authors
Journal
The Korean Journal of Hematology
1738-7949
Publisher
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis (KAMJE)
Publication Date
Volume
47
Issue
3
Identifiers
DOI: 10.5045/kjh.2012.47.3.194
Keywords
  • Original Article
Disciplines
  • Medicine

Abstract

Background Iron is essential for cell proliferation and viability. It has been reported that iron depletion by a chelator inhibits proliferation of some cancer cells. Deferasirox is a new oral iron chelator, and a few reports have described its effects on lymphoma cells. The goal of this study was to determine the anticancer effects of deferasirox in malignant lymphoma cell lines. Methods Three human malignant lymphoma cell lines (NCI H28:N78, Ramos, and Jiyoye) were treated with deferasirox at final concentrations of 20, 50, or 100 µM. Cell proliferation was evaluated by an MTT assay, and cell cycle and apoptosis were analyzed by flow cytometry. Western blot analysis was performed to determine the relative activity of various apoptotic pathways. The role of caspase in deferasirox-induced apoptosis was investigated using a luminescent assay. Results The MTT assay showed that deferasirox had dose-dependent cytotoxic effects on all 3 cell lines. Cell cycle analysis showed that the sub-G1 portion increased in all 3 cell lines as the concentration of deferasirox increased. Early apoptosis was also confirmed in the treated cells by Annexin V and PI staining. Western blotting showed an increase in the cleavage of PARP, caspase 3/7, and caspase 9 in deferasirox-treated groups. Conclusion We demonstrated that deferasirox, a new oral iron-chelating agent, induced early apoptosis in human malignant lymphoma cells, and this apoptotic effect is dependent on the caspase-3/caspase-9 pathway.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

[Deferasirox--a new oral iron chelator--review].

on Zhongguo shi yan xue ye xue za... October 2010

Deferasirox: the new oral iron chelator.

on Indian Pediatrics August 2007

Deferasirox: An effective once-daily orally active...

on Drugs of today (Barcelona, Spa... October 2006

Deferasirox: oral, once daily iron chelator--an ex...

on The Indian Journal of Pediatri... February 2010
More articles like this..